These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22114188)

  • 1. Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.
    Hatakeyama S; Sugihara K; Shibata TK; Nakayama J; Akama TO; Tamura N; Wong SM; Bobkov AA; Takano Y; Ohyama C; Fukuda M; Fukuda MN
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19587-92. PubMed ID: 22114188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting by a carbohydrate ligand-mimicking peptide.
    Hatakeyama S; Shibata TK; Tobisawa Y; Ohyama C; Sugihara K; Fukuda MN
    Methods Mol Biol; 2013; 1022():369-86. PubMed ID: 23765676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor vasculature-targeted
    Yoneyama T; Hatakeyama S; Sutoh Yoneyama M; Yoshiya T; Uemura T; Ishizu T; Suzuki M; Hachinohe S; Ishiyama S; Nonaka M; Fukuda MN; Ohyama C
    BMC Cancer; 2021 Jan; 21(1):72. PubMed ID: 33446132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
    Nonaka M; Mabashi-Asazuma H; Jarvis DL; Yamasaki K; Akama TO; Nagaoka M; Sasai T; Kimura-Takagi I; Suwa Y; Yaegashi T; Huang CT; Nishizawa-Harada C; Fukuda MN
    PLoS One; 2021; 16(1):e0241157. PubMed ID: 33406123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
    Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retro-inverso carbohydrate mimetic peptides with annexin1-binding selectivity, are stable in vivo, and target tumor vasculature.
    Chen X; Fan Z; Chen Y; Fang X; Sha X
    PLoS One; 2013; 8(12):e80390. PubMed ID: 24312470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate mimetic peptides as research reagent and therapeutic.
    Fukuda MN; Hatakeyama S; Sugihara K
    Biol Pharm Bull; 2012; 35(10):1626-32. PubMed ID: 23037151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography imaging of a novel Anxa1-targeted peptide
    Chen F; Xiao Y; Shao K; Zhu B; Jiang M
    J Labelled Comp Radiopharm; 2020 Oct; 63(12):494-501. PubMed ID: 32562502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
    Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature.
    Liu Y; Kim YJ; Siriwon N; Rohrs JA; Yu Z; Wanga P
    Biotechnol Bioeng; 2018 Jun; 115(6):1403-1415. PubMed ID: 29457630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
    Yamazaki R; Nishiyama Y; Furuta T; Hatano H; Igarashi Y; Asakawa N; Kodaira H; Takahashi H; Aiyama R; Matsuzaki T; Yagi N; Sugimoto Y
    Mol Cancer Ther; 2011 Jul; 10(7):1252-63. PubMed ID: 21566063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
    Oliver PG; LoBuglio AF; Zinn KR; Kim H; Nan L; Zhou T; Wang W; Buchsbaum DJ
    Clin Cancer Res; 2008 Apr; 14(7):2180-9. PubMed ID: 18381960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine.
    Verreault M; Strutt D; Masin D; Anantha M; Yung A; Kozlowski P; Waterhouse D; Bally MB; Yapp DT
    BMC Cancer; 2011 Apr; 11():124. PubMed ID: 21477311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.
    Vangestel C; Van de Wiele C; Van Damme N; Staelens S; Pauwels P; Reutelingsperger CP; Peeters M
    J Nucl Med; 2011 Nov; 52(11):1786-94. PubMed ID: 22045708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A d-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma Cells.
    Ren Y; Zhan C; Gao J; Zhang M; Wei X; Ying M; Liu Z; Lu W
    Mol Pharm; 2018 Feb; 15(2):592-601. PubMed ID: 29283582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
    Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
    Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors.
    Proia DA; Smith DL; Zhang J; Jimenez JP; Sang J; Ogawa LS; Sequeira M; Acquaviva J; He S; Zhang C; Khazak V; Astsaturov I; Inoue T; Tatsuta N; Osman S; Bates RC; Chimmanamada D; Ying W
    Mol Cancer Ther; 2015 Nov; 14(11):2422-32. PubMed ID: 26271675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of quercetin combined with anticancer drugs on metastasis-associated factors of gastric cancer cells: in vitro and in vivo studies.
    Lei CS; Hou YC; Pai MH; Lin MT; Yeh SL
    J Nutr Biochem; 2018 Jan; 51():105-113. PubMed ID: 29125991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors.
    Chang DK; Chiu CY; Kuo SY; Lin WC; Lo A; Wang YP; Li PC; Wu HC
    J Biol Chem; 2009 May; 284(19):12905-16. PubMed ID: 19276080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.